会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明申请
    • Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
    • 用于开发治疗剂的试验系统,特别是治疗骨质疏松症的活性化合物
    • US20040265837A1
    • 2004-12-30
    • US10622377
    • 2003-07-18
    • Thomas J. Jentsch
    • C12Q001/68A01K067/00C07H021/04C07K014/705
    • C07K14/705A01K2217/075
    • The present invention relates to a test system for the identification and testing of active compounds which act on synapic transmission (active compounds for treatment of neuronal diseases), which influence endo/exocytosis, which influence processing of proteins and in particular of active compounds which can be used for treatment of osteoporosis or Paget's disease, for treatment of neurological and neuromuscular diseases and other nerve diseases or as psychotropic pharmaceuticals. The invention furthermore relates to a genetically modified non-human mammal, in which one or more chloride channels from the group consisting of CIC-3. CIC-4, CIC-6 and CIC-7 are not expressed or are expressed non-functionally, and somatic cell lines which are derived from such an animal, and the use thereof for the identification and testing of substances which are suitable for inhibiting chloride channels, in particular CIC-3, CIC-4, CIC-5, CIC-6 and/or CIC-7.
    • 本发明涉及一种用于鉴定和检测影响内吞/胞吐作用的活化化合物的作用于突触传递的活性化合物(用于治疗神经元疾病的活性化合物),其影响蛋白质,特别是活性化合物的加工,其可以 用于治疗骨质疏松症或佩吉特氏病,用于治疗神经和神经肌肉疾病和其他神经疾病或作为精神药物。 本发明还涉及一种遗传修饰的非人哺乳动物,其中一个或多个来自CIC-3的氯化物通道。 CIC-4,CIC-6和CIC-7不表达或非功能表达,并且衍生自这种动物的体细胞系及其用于鉴定和测试适于抑制氯化物的物质的用途 通道,特别是CIC-3,CIC-4,CIC-5,CIC-6和/或CIC-7。
    • 36. 发明申请
    • Method of sorting vesicle-entrapped, coupled nucleic acid-protein displays
    • 分离囊泡夹带的偶联核酸蛋白质显示器的方法
    • US20040265835A1
    • 2004-12-30
    • US10610024
    • 2003-06-30
    • David M. LemasterJames H. Jett
    • C12Q001/68C07H021/04C12P021/04C12N009/00C12N001/18
    • C40B40/02C07H21/04C12N15/1037
    • A method for identifying and sorting variants of a chosen enzyme is disclosed. Enzyme variants of a chosen enzyme are obtained and then linked to their corresponding genetic code through any of a family of suitable surface display methods. The enzyme variants, now displayed on the surface of a biological particle such as a phage, virus, yeast, or bacterium are then encapsulated in a vesicle containing an enzyme activity-sensitive assay reagent. The enzyme variant is thus exposed to the assay reagent, and displays a signal using the enzyme activity-sensitive assay reagent in a manner proportionate to the levels of activity of the enzyme, thus rendering the vesicles suitable for mechanical sorting based on these levels. The vesicles are then sorted using methods known in the art to isolate those variants exhibiting possibly beneficial variations in enzyme function.
    • 公开了用于鉴定和分选所选酶的变体的方法。 获得选择的酶的酶变体,然后通过任何一种合适的表面显示方法与其相应的遗传密码连接。 然后将现在显示在诸如噬菌体,病毒,酵母或细菌的生物颗粒的表面上的酶变体包封在含有酶活性敏感性测定试剂的囊泡中。 因此,酶变体暴露于测定试剂,并且以与酶的活性水平成比例的方式使用酶活性敏感的测定试剂显示信号,从而使得囊泡适合于基于这些水平的机械分选。 然后使用本领域已知的方法分选囊泡,以分离显示可能有益的酶功能变化的那些变体。